Full-Time

Team Lead--Cancer Cell Signaling

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures vaccines and medicines

Biotechnology
Healthcare

Compensation Overview

$149.2k - $248.6kAnnually

+ Bonus

Senior, Expert

No H1B Sponsorship

La Jolla, San Diego, CA, USA

Relocation support available.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD or MD/PhD in Molecular or Cellular Biology, Pharmacology or a relevant biological science
  • Minimum of 10 years of relevant industry experience in a pharmaceutical/biotech environment.
  • Experience leading and managing laboratory-based teams with familiarity with biological assays supporting drug discovery programs
  • Strong track record of advancing drug discovery programs employing traditional small molecule inhibitors as well as emerging chemical proximity approaches.
  • Strong written and verbal communication skills
  • In-depth knowledge of cell biology and molecular biology techniques:--should be well-versed in the fundamental and advanced techniques used in the field.
Responsibilities
  • Lead a biology team in the successful support of small molecule drug discovery projects.
  • Provide scientific leadership toward selection of novel oncology drug discovery targets and programs.
  • Lead multidisciplinary small molecule drug discovery project teams in the delivery of novel cancer therapeutic candidates.
  • Collaborate across the Oncology Research Unit to advance scientific and portfolio priorities.
  • Grow your team to maximize colleague engagement and development and ensure scientific excellence.
  • Promote the scientific contributions of Pfizer Oncology through publications and external scientific communications.

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold to various clients such as governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, oncology treatments, and other specialized medicines. A notable achievement is its partnership with BioNTech to develop a vaccine for COVID-19, which has played a significant role in addressing the pandemic. Pfizer aims to improve public health by ensuring access to vaccines, especially for underserved populations, and continues to grow its product offerings with new approvals and treatments.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Pfizer's significant investments in companies like CellCentric and Caribou Biosciences indicate a strong focus on expanding its oncology and cell therapy capabilities.
  • The company's proactive approach in securing investments and partnerships positions it well for future growth and innovation in the biopharmaceutical sector.
  • Pfizer's involvement in funding rounds for promising biotech firms suggests potential for lucrative returns and strategic advancements in healthcare solutions.

What critics are saying

  • The slowdown in demand for COVID-19 vaccines could impact Pfizer's revenue and market perception.
  • Activist investor involvement, such as Starboard Value's $1 billion stake, may lead to pressure for strategic changes that could affect company stability.

What makes Pfizer unique

  • Pfizer's strategic partnerships and investments in innovative biotech companies like Promise Bio and Enara Bio highlight its commitment to cutting-edge research and development.
  • The company's collaboration with BioNTech for the COVID-19 vaccine showcases its ability to rapidly respond to global health crises, setting it apart from many competitors.
  • Pfizer's diverse portfolio, including oncology and specialized medicines, ensures a broad market reach beyond just vaccines.

Help us improve and share your feedback! Did you find this helpful?